Today: 2 July 2026
Sidus Space stock jumps 33% as $16.2 million share sale settles
31 December 2025
1 min read

Sidus Space stock jumps 33% as $16.2 million share sale settles

NEW YORK, December 31, 2025, 2:48 PM ET — Regular session

  • Sidus Space shares rose about 33% in afternoon trading on Nasdaq.
  • The move follows the company’s closing of a $16.2 million public share offering.
  • Traders are weighing fresh cash proceeds against dilution from newly issued stock.

Shares of Sidus Space, Inc. (SIDU) jumped about 33% to $3.56 by 2:48 p.m. ET on Wednesday. The stock traded between $2.48 and $3.74, with about 112.7 million shares changing hands.

The rally comes two sessions after Sidus said it closed a best-efforts public offering, raising about $16.2 million in gross proceeds by selling 10.8 million shares at $1.50 each. The company said it plans to use the funds for sales and marketing, operating costs, product development, manufacturing expansion, and working capital.

That matters for investors because financing terms can drive short-term trading in microcap stocks, especially when new shares are issued at a steep discount to where the stock later trades. New capital can extend runway, but it also increases share count and can pressure prices if holders sell.

A U.S. securities filing dated Dec. 29 outlined fees tied to the deal. Sidus said it agreed to pay ThinkEquity a 7% cash fee, reimburse up to $125,000 in expenses, and issue warrants to buy up to 540,000 shares at $1.875 per share, exercisable immediately with a five-year term.

A “registered direct” offering is a sale of newly issued shares to investors using an existing SEC registration, rather than an unregistered private placement. It can speed up fundraising, but it still dilutes existing shareholders.

Wednesday’s surge left Sidus trading well above the $1.50 offering price. The placement-agent warrants are also in the money at current levels, meaning they can add to dilution if exercised.

Moves in small U.S. space and satellite-linked names were mixed. Redwire was down about 4.3%, while Spire Global slipped about 2.5%.

For traders, the next focus is whether the stock can stabilize after a wide intraday range and heavy volume, or whether the financing-driven move fades into the close.

Investors are also watching for follow-on disclosures tied to the offering, including any updates on share issuance and how quickly proceeds translate into manufacturing expansion and product development. Sidus’ investor calendar currently lists no upcoming events.

With the cash raise now complete, attention turns back to execution: landing contracts, scaling production, and showing progress toward revenue that can reduce reliance on frequent equity sales.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Tech Stocks Push S&P/TSX Up; U.S. Markets Trade Mixed
    July 2, 2026, 11:46 AM EDT. The S&P/TSX composite index added 73.10 points to finish at 34,930.09, lifted by tech names. On Wall Street, the Dow jumped 410.55 points to 52,715.79. S&P 500 posted a small gain, up 3.04 to 7,486.27, while the Nasdaq slipped 169.99 points to 25,870.04. The Canadian dollar ticked up to 70.50 cents US. August crude settled $1.04 lower at $67.54 a barrel. Gold rallied $52.60 to $4,135.00. Oil and gold futures moved as traders sized up commodity sentiment.
HFCL jumps 10% on heavy volumes even as MarketsMojo keeps “Strong Sell” callNEW YORK, December 29, 2025, 00:11 ET
Previous Story

HFCL jumps 10% on heavy volumes even as MarketsMojo keeps “Strong Sell” callNEW YORK, December 29, 2025, 00:11 ET

Eli Lilly stock dips after hours as Jardiance, Mounjaro price-cut headlines land into 2026
Next Story

Eli Lilly stock dips after hours as Jardiance, Mounjaro price-cut headlines land into 2026

Go toTop